MedTrace Logo

Efficacy and Safety of Sublingual Immunotherapy (SLIT)

NCT01012882 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2015-11-03

No results posted yet for this study

Summary

The purpose of this study is to evaluate the efficacy and safety of specific sublingual immunotherapy (SLIT) with allergen extracts in patients suffering from seasonal allergic rhinitis .

Conditions

  • Allergic Rhinitis

Interventions

BIOLOGICAL

sublingual immunotherapy with allergen extract

sublingual application

BIOLOGICAL

sublingual immunotherapy with placebo

sublingual application

Sponsors & Collaborators

  • Roxall Medizin

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-11-30
Primary Completion
2017-11-30
Completion
2017-11-30

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01012882 on ClinicalTrials.gov